chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a registered nurse concerning a child who developed chicken pox after being exposed to another child who, on an unspecified date, was vaccinated with Varivax. The nurse reported that the child who received the vaccination with Varivax did not develop a rash and the child who developed the chickenpox may have been exposed to other children with natural varicella infections. Unspecified medical attention was sought. Additional information has been requested.
I got the shot in my right arm and it hurt the next day and I didn't think too much about it. The day after that it hurt really bad. By day 2 or 3 I started noticing that when I lean on that side it really hurt and when I touched it it was hot and swollen like a golf ball size. It hurt like hell for 3-4 days and by 7 days it went away. 3 weeks later I caught Covid. Symptoms were mild. I've caught Covid 2 times after my vaccine, I had it 1 time before the vaccine.
J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 3/28/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA J96.02 ACUTE HYPERCAPNIC RESPIRATORY FAILURE 3/28/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA J96.12 CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 3/9/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 3/28/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA J96.02 ACUTE HYPERCAPNIC RESPIRATORY FAILURE 3/28/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA J96.12 CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 3/9/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 3/28/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA J96.02 ACUTE HYPERCAPNIC RESPIRATORY FAILURE 3/28/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA J96.12 CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 3/9/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA
Feeling bone chilling cold, coughing, wheezing, feeling disoriented. Low body temperature, 95 degrees. Couldn't stay awake. Whole body pain, joints, muscles, bones.  Even my eyelashes hurt. Lasted about 8 hours.
Swelling in (R) deltoid within a day of having immunizations. Gradually increasing: ER 8/22- swollen. ER 8/28- fluid drained, cultured negative antibiotics started office visit 8/30, 9/14 -> still swollen ultrasound ordered.
Infant rec'd PENTACEL 3/3/09 @ 2mo.  well-child on 3/16/09 called nurse line - (mom) stating child non stop screaming.  This office called back 3/9 - spoke with mom - who stated child ok (spoke for mom who was not feeling well) today @ 4mo WCC- mom states child screamed x1 wk after 2 mo imms & it took x3d to be able to comfort & console infant.  *Note 3/6 phone call 6:33 pm-closed office called 3/9 when office back opened.
Swelling redness radiating 2 inches from injection site. Treating with ibuprofen for pain/swelling as per doctor's instructions.
Patient was seen 3/30/04 16:30 PM, for puncture wound left index finger through and through with drill. Patient received a Td injection right deltoid, lot Td111. On 4/3/04, patient went to the ER and the on call physician said patient presented with complaint of pain, swelling and redness of his right deltoid (the site of the Td injection). On exam he was noted to have a tender, swollen, indurated, erythematous deltoid region. Per doctor, an attempt at aspiration was made by orthopedics at the time of admission but no fluid was obtained and therefore no culture was available. The patient was treated empirically with vancomycin with full resolution of symptoms. Doctor discharged the patient on Keflex on 4/7/04. Doctor informed patient it was unlikely that right arm infection and left hand injury were related.
she had a really bad taste in her mouth (later stated as a "strong medicine taste"); nausea; stomachache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Lot number of the first booster shot: FK9894., DOSE NUMBER UNKNOWN,(BOOSTER), SINGLE), for covid-19 immunization; Covid-19 vaccine (Primary immunization completed, unknown manufacture.), for covid-19 immunization. The following information was reported: DYSGEUSIA (non-serious), outcome "not recovered", described as "she had a really bad taste in her mouth (later stated as a "strong medicine taste")"; NAUSEA (non-serious), outcome "not recovered"; ABDOMINAL PAIN UPPER (non-serious), outcome "not recovered", described as "stomachache".  Additional Information:  Caller received the 2nd booster shot of the Pfizer-BioNTech Covid 19 Vaccine on Friday and immediately she had a really bad taste in her mouth (later stated as a "strong medicine taste"). 3 hours later the patient had nausea and stomach-ache. Today was the 5th day and she still had it. Her main concern was the terrible taste in her mouth and wants to know if it could be possible that the vaccine went directly to her veins once she received the shot. The taste did not happened with the first booster and she did not think that it could be due to the swap of alcohol she made.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
in April I had 'knee' replacement done; head to toe rash and I have been kind of dealing with ever since; Shortness of breath; In march I got the Pfizer vaccine and two weeks later I went and got the second dose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (dose 1, single), administration date: Mar2021, for COVID-19 immunization. The following information was reported: INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 2021, outcome "unknown", described as "In march I got the Pfizer vaccine and two weeks later I went and got the second dose"; KNEE ARTHROPLASTY (medically significant) with onset Apr2021, outcome "unknown", described as "in April I had 'knee' replacement done"; RASH (non-serious) with onset Apr2021, outcome "unknown", described as "head to toe rash and I have been kind of dealing with ever since"; DYSPNOEA (non-serious) with onset Apr2021, outcome "unknown", described as "Shortness of breath". It was reported that patient had a question that In Mar got the Pfizer vaccine and two weeks later went and got the second dose and then in Apr had 'knee' replacement done about two weeks after that patient started with this really head to toe rash and had been kind of dealing with ever since and shortness of breath. Now they put patient on prednisone and was on prednisone for like two or three months to be honest with you. They couldn't figure out they can't figure out what's wrong with patient so anyway went in to withheld and got Pfizer booster shot last Monday well started breaking out head to toe with the rash again and I am just trying, I am asking do you think this is a side effect of Pfizer or this is something else. I just wanted to double check I am not sure." Patient stated, was looking at little dog and had to get him out to the bathroom before he has an accident. Therapeutic measures were taken as a result of knee arthroplasty, rash, dyspnoea. The patient received treatment of prednisone for like two or three months for adverse events.  The lot number for bnt162b2 was not provided and will be requested during follow up.
tinnitus; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 49 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 23Apr2021 12:00 (Batch/Lot number: unknown) at the age of 49 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: TINNITUS (non-serious) with onset 2021, outcome "recovered" (2021), described as "tinnitus". Therapeutic measures were not taken as a result of tinnitus.  Additional information: No other vaccine in four weeks and no other medications in two weeks. No known allergies. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. Reported that, after first dose, patient had a little tinnitus after a week but went away. Did not know this was a side effect of Covid vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
pt says about a week after taking vax she has joint pain in right elbow and her arm is swollen.  Pt contacted her PCP and was told to use ice packs.  Pts symptoms never went away before getting second dose and now they have gotten worse.  Pt will see her PCP on 5/21/21.
Patient received vaccine on 12/31/2020.  Patient was on day 4 of antibiotics for UTI when she received the vaccine on 12/31/2020.  On 1/6/2021, patient started to experience a rash and difficulty breathing and went to the ER.  The ER started her on a new antibiotic.  Both antibiotics that she received, she has been on before and has never had a reaction.
Information has been received from the registered nurse concerning to an approximately 76 year old patient of unknown gender. Patient's concurrent conditions and relevant medical history was not reported. On 11-FEB-2015, the patient was vaccinated with improperly stored dose of PNEUMOVAX 23 (lot number: K005402 with unknown expiration date) (dose, route and frequency unspecified). Concomitant medications were not reported. No adverse event was reported. The outcome of the event was unknown. The causality of the events with PNEUMOVAX 23 was not reported. This is one of the several reports from the same reporter. Additional information has been requested.
Information has been received from a health professional concerning a 1 day old female baby who was born on 30-MAR-2010 at 30 weeks gestation from a patient who on 21-SEP-2009 was vaccinated with a third dose of GARDASIL (Lot# unknown).  On 30-MAR-2010, the baby was diagnosed with respiratory distress syndrome, and was transferred to the neonatal intensive care unit (NICU) where she was treated with antibiotics for sepsis.  The baby was discharged on 16-MAY-2010.  The reporter read the discharge note and discharge exam.  Per the discharge note of 16-MAY-2010 from the NICU: The baby also had a diagnosis of apnea and bradycardia, with poor suck/swallow breath coordination, and hyperbilirubinemia.  Her heart rate was 150 bpm, respiratory rate 40, blood pressure 85/50, temperature 36.4 centigrade, weight 3124 grams, length 48 cm.  Skin: no rash or lesions noted.  Ears, nose, and throat examination (HEENT): normal cephalic.  Anterior fontanel was flat.  Respiratory breath sounds: clear, equal and easy.  Cardiovascular: regular heart rate and rhythm without an audible murmur.  Skin pink with no edema, Abdomen soft with positive bowel sounds, no organomegaly noted.  Moves all extremities well, no hip click.  Neurological: appropriate tone for gestational age.  Rectal: anus is patent.  Reported to be a generally normal female.  At the time of the report, the outcome of the patient was unknown.  Upon internal review the premature was considered to be an other important medical event.  The mother's experience has been captured in WAES# 0912USA00624.  Additional information has been requested.
L upper arm 1 cm & 3 (1-3 mm) urticarial wheals (lesions).  Central blanching & surrounding 3 cm area of erythema and redness.  Started 20 min ago just after lunch.  Had influenza vaccine yesterday.
"history of multiple allergic type reactions in the past is presenting for itching and the feeling of hoarse voice after receiving the first Covid vaccine.  Here, she is slightly tachycardic, but her oxygen level is good, her lungs are clear.  She has no urticaria, she has no stridor or wheezing.  She does not wish to receive epinephrine because she has had such bad effects from it in the past, and is agreeable to Solu-Medrol and Benadryl.  She took Pepcid prior to having her injection.  Her friend who is with her recommends that she has a history of severe events like this in the past, and she usually does better after breathing treatment.  However, patient states that she often ends up on BIPAP" PER ED MD NOTE
This spontaneous report as received from a from pharmacy technician concerning a currently 16 years old adolescent. Gender was not reported. Medical history and concurrent conditions were not reported. On 05-MAR-2014, the patient was vaccinated with VARIVAX lot #J007955; expiration date: 27-JUN-2015, (dose, strength and route were not reported). Secondary and concomitant therapies were not reported. Patient was vaccinated with VARIVAX that was exposed to 43.1 degrees F for 29 hours on 03-MAR-2014. This is one of several reports from the same reporter. Additional information has been requested.
Patient admitted for acute hypoxic respiratory failure, COPD exacerbation , subsequently found COVID1-9 positive.
pt recvd vax APR90 & 15-20 days later noticed pt had non stop crying for several hrs then calmed down & went to sleep;later father noticed pt was not progressing taken to MD who noted exaggerated reflexes w/no etiology & dx infantile spasms
The patient presented his covid card and only had the 1st dose filled in , He said he needed the second shot.  He filled out his paperwork, and it looked good after review , so the vaccination was given.  when the technician proceeded billing, the system showed that he had already received  2 doses.   However his card was not filled out.  I wanted to report because the patient may have received 3 doses of Moderna.  I have checked with the patient each day, and he is completely fine AND HE HAS NO ADVERSE EFFFECTS.    I just wanted to report this .
That evening, patient's arm started to swell around injection site and was red and warm to touch. Patient "felt bad" and had fever and chills. Patient went to an emergent care clinic where he was treated with antibiotics prophylactically to rule out infection. The site of reaction was on the right arm. Patient was also seen by primary care provider and believed to be AE to pneumonia vaccine.
8/5/05 mothers states pt broke out in a generalized rash four days after receiving MMR. Pt was seen in clinic by MD 8/16/05. MD reported observing large flat macule and changes in size and hot at imm.
On the next day my joints (especially Knees) swelled up and I could not walk by afternoon, my rheumatologist prescribed prednisone 20mg and by saturday I had  relief of pain. Swelling remained until sunday. I continued to take the prednisone 20mg daily and on Sunday night my tongue, esophagus and neck swelled so much I could not swallow but my breathing was not impaired. I took benedryl 50mg, zantac 300mg. By Monday afternoon the swelling was gone. I notified both the IM doc and my rheumatologist and am continuing on prednisone.
mild fever; chills; Booster; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 49 year-old male patient received bnt162b2 (COMIRNATY), administration date 02Dec2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "mild high cholesterol" (unspecified if ongoing), notes: mild high cholesterol for which he takes Lipitor. The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (1st dose, Primary Immunization series complete but unknown manufacturer), for COVID-19 immunization; Covid-19 vaccine (2nd dose, Primary Immunization series complete but unknown manufacturer), for COVID-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 02Dec2021, outcome "unknown", described as "Booster"; PYREXIA (non-serious) with onset 04Dec2021, outcome "recovered" (04Dec2021), described as "mild fever"; CHILLS (non-serious) with onset 04Dec2021, outcome "recovered" (04Dec2021), described as "chills".  Additional information : It was reported that Patient received booster on the afternoon of 02Dec2021 and started experiencing events while sleeping in the early morning of 04Dec2021 and the symptoms were transient and resolved within a few hours.Event took place after use of product. The patient was taking Lipitor for mild high cholesterol.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Shot was given in left upper arm. The next day, arm swelled and started to be painful to the touch. It is still painful to use and swell at times.
shingles; tenderness to the touch on the right side of her face, temple and eye and up into her scalp; tenderness to the touch on the right side of her face, temple and eye and up into her scalp; tenderness to the touch on the right side of her face, temple and eye and up into her scalp; area is itchy/right eye is itchy in the corner; area is itchy, achy including the whole right side of her forehead; headache; right eye is itchy in the corner; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 78-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of herpes zoster (received 8 years ago).   On 27th August 2020, the patient received the 1st dose of Shingrix. On 14th September 2020, 18 days after receiving Shingrix, the patient experienced shingles, eye tenderness, facial pain, scalp tenderness, pruritus, pain, headache and eye pruritus. On an unknown date, the outcome of the shingles was unknown and the outcome of the eye tenderness, facial pain, scalp tenderness, pruritus, pain, headache and eye pruritus were not recovered/not resolved.   It was unknown if the reporter considered the shingles, eye tenderness, facial pain, scalp tenderness, pruritus, pain, headache and eye pruritus to be related to Shingrix.  Additional details were provided as follows: The patient reported that she had the previous shingles vaccine 8 years ago and she got shingles. The patient reported that she had the first dose of Shingrix on 27th August 2020. A week before the time of reporting the patient started to get shingles symptoms including tenderness to the touch on the right side of her face, temple and eye and up into her scalp. The patient claimed that the area was itchy, achy including the whole right side of her forehead.  The patient had a headache on and off and her right eye was itchy in the corner.  The reporter claimed that the symptoms she was experiencing were not bad enough to see a physician. The reporter called back on 23rd September 2020 to provide date of birth. The reporter consented to follow up.
Patient came to the emergency department on 8/20/22 with 3 days of dyspnea and cough. COVID+ on 8/20/22. Patient on 3L Nasal Canula
pt recv vax & lt arm became swollen, hand getting bigger;went to ER;10FEB ER tx notes indicate pain/swelling/red x 3 days & cellulitis noted;lt arm still large indurated/red;
Patient is a 83 y.o. female patient with history of CAD, paroxysmal A-fib on anticoagulation, ischemic cardiomyopathy, diabetes type 2 insulin-dependent, hypertension, dyslipidemia brought in to Hospital with altered mental status and acute respiratory failure.   Acute hypoxic respiratory failure, resolved COVID-19 On admission O2 sat 60%, required NRB and later transitioned to BiPAP in the ED but was able to wean down to RA COVID test positive on 2/14. CRP 132.1> 37 Patient completed isolation. Speech evaluated.  Recommended ground meats and thin liquids. Enrolled in hospice at discharge.  DC home with hospice   C. Difficile Placed on oral vancomycin and continued at discharge to complete 10 days course Isolation precautions Diarrhea improved Continues with poor oral intake  Metabolic encephalopathy, improved Lewy body dementia Patient was hard to arouse in the ER Likely due to hypoxia and UTI. Urine drug screen positive for opiates but patient not on opiates at nursing home. Responded some to Narcan CT brain-no acute intracranial abnormality. Unable to do MRI brain due to pacemaker Recurrent admissions for altered mental status Consulted neurology-waxing and waning mentation consistent with Lewy body dementia potentially exacerbated by recurrent infections. Continue Aricept and Namenda.   Urinary tract infection Urine culture:> 100,000 Enterobacter cloacae Blood cx NGTD Completed antibiotic therapy     Paroxysmal A-fib Ischemic cardiomyopathy S/p DCCV on 2/2/2023, now in sinus rhythm Continue metoprolol, amiodarone 200 mg daily   Hypertension Blood pressure stable continue Toprol-XL 25 daily   Diabetes type 2 insulin-dependent Home Rx; Lispro SSI.   Patient was hyperglycemic initially likely due to steroid and was started on Lantus but titrated down to 5 units HS and DC home on same dose. As patient is enrolling in hospice discontinued lispro SSI AC&HS Hemoglobin A1c from 1/29/2023--6.5% AKI on CKD stage III, resolved Baseline creatinine around 1.5. Admit Cr 1.6, trended up to 2.0, trended down to 1.11 Hydrated with IV fluids Held home Aldactone 12.5 mg daily but restarted No further blood draws.   Goals of Care CODE STATUS: DNR CCA Patient was not eating or drinking, not participating in therapy. Discussed with daughter about the option of feeding tube/hospice Daughter wants hospice to be consulted.  Hospice saw patient.  Patient not a candidate for inpatient hospice. DC home with hospice
6/17/08 9p: achy enough to take MOTRIN (L) arm w/ Tdap. 6/18/08 7am: unable to move arm/achy joints, took MOTRIN. Noon: fever; fatigue; pain; sleeplessness. 4p: severe pain and swelling at site. Very achy joints. 9p: worse yet. Lasted until Fri morning.
Itchy rash  on face, trunk, left, and right arm; started at 12:00 pm on 1/19/2022.  Treated with otc benedryl.   Faded at 8 pm 1/19/2022.  Face rash presented again 1/20/2022 at 8 am.  Treated again with otc benedryl.  Low grade fever, fatigue, muscle pain started at 2:00 pm 1/19/2022.  Treated with otc ibuprofen.  Fever and muscle aches continued thru 1/20/2022.
Started itching and rash developed 7.5 days after dose at injection site. Left armpit close to chest sore, started a few days after vaccine and has been ongoing.
Patient states her injection site raised, red , warm and tender.  Patient is instructed to use warm moist compress, tylenol, Hydrocortisone cream. Call back if needs to be seen.  Patient denies any SOB or swollen lips or additional sx.
fatigue; upset stomach; Still experiencing headache; This is a spontaneous report from a contactable consumer (Patient) reported for himself. A 59-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in left arm on 08Mar2021 at 08:00 as 2nd dose single for covid-19 immunization. The patient previously received first dose of BNT162B2 on 15Feb2021 via unspecified route, administered in right arm on 15Feb2021 as 1st dose single for covid-19 immunization. The patient medical history was not reported. Concomitant medication included Losartan for blood pressure and Multivitamin Active. On 09Mar2021, after the second dose of Covid-19 vaccine, the patient experienced headaches for a week. He heard of 24-36 hours, but this is dragging. On 11Mar2021, the patient experienced upset stomach and fatigue The outcome of the events Still experiencing headache and upset stomach were not recovered and fatigue was unknown.  Information on the lot/batch number has been requested. Follow-up attempts completed. No further information expected.
patient fainted, had him sit down, drink water and a piece of candy. pt reported feeling much better